Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mohammadali, Nikoo"'
Autor:
Vivian W. L. Tsang, James S.H. Wong, Jean N. Westenberg, Noor H. Ramadhan, Hasti Fadakar, Mohammadali Nikoo, Victor W. Li, Nick Mathew, Pouya Azar, Kerry L. Jang, Reinhard M. Krausz
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
ObjectivesFentanyl is a highly potent opioid and has, until recently, been considered an unwanted contaminant in the street drug supply among people who use drugs (PWUD). However, it has become a drug of choice for an increasing number of individuals
Externí odkaz:
https://doaj.org/article/1b006e1650c84f5dab429541b81cfc12
Autor:
James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Y. C. Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew, Pouya Azar
Publikováno v:
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background Buprenorphine/naloxone (Suboxone) is a current first-line treatment for opioid use disorder (OUD). The standard induction method of buprenorphine/naloxone requires patients to be abstinent from opioids and therefore experience wit
Externí odkaz:
https://doaj.org/article/f8edda90e3b64dd1b3a9334a2ff5dc08
Autor:
Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo, S. Elise Durante, Skye P. Barbic, Daniel Lin, Steve Mathias, Pouya Azar
Publikováno v:
Addiction Science & Clinical Practice, Vol 15, Iss 1, Pp 1-6 (2020)
Abstract Background The requirement for moderate withdrawal prior to initiation can be a barrier to buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing regimen to initiate regular dosing of buprenorphine/naloxone in a hi
Externí odkaz:
https://doaj.org/article/42522561508c4de4bc551d2e3a27946b
Autor:
Raman Sandhu, Rebecca Zivanovic, Sukhpreet Klaire, Mohammadali Nikoo, Jennifer Rozylo, Pouya Azar
Publikováno v:
Canadian Journal of Pain, Vol 3, Iss 1, Pp 79-84 (2019)
Background Due to its unique pharmacologic properties, efficacy as an analgesic, and role as a first-line medication for the treatment of opioid use disorder, sublingual buprenorphine has emerged as a treatment for patients with concurrent chronic pa
Externí odkaz:
https://doaj.org/article/9e7c9d627be04237b0faf4c23bb43051
Autor:
Angelo G. I. Maremmani, Silvia Bacciardi, Julian M. Somers, Mohammadali Nikoo, Christian Schütz, Kerry L. Jang, Michael Krausz
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
Introduction: Homeless individuals are often mischaracterized as members of a homogeneous population that suffers from a wide mental health and addiction issues, with little consideration of potentially important differences within or between samples
Externí odkaz:
https://doaj.org/article/253e504fd2d54d208a30774242987f84
Publikováno v:
European Addiction Research. 27:304-310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6370a255b2d5b6384dd9d10275a999d1
https://doi.org/10.1159/000508128
https://doi.org/10.1159/000508128
Autor:
Kiana Yazdani, Mohammadali Nikoo, Fiona Choi, Kerry Jang, Reinhard Michael Krausz, Eric C. Sayre
Publikováno v:
Social Psychiatry and Psychiatric Epidemiology. 55:1619-1627
To assess impact of employment on recovery in a sample of adults from Vancouver At Home (VAH) study, who were homeless and were diagnosed with severe mental disorders. The VAH included two randomized controlled trials investigating the effect of hous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b0ea4593abf680dadf04918d4161ef
https://doi.org/10.1007/s00127-020-01887-9
https://doi.org/10.1007/s00127-020-01887-9
Autor:
Sara Jassemi, Pouya Azar, Samantha Young, Eva Moore, Mohammadali Nikoo, James S H Wong, Dzung X Vo
Publikováno v:
The American Journal on Addictions. 29:531-535
Background and objectives Buprenorphine extended-release (BUP-XR) is a monthly injectable form of opioid agonist therapy. Before its administration, a minimum 7-day induction period with a transmucosal buprenorphine-containing product is recommended.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d82cab3abfdb799e3d8640d534b7693
https://doi.org/10.1111/ajad.13050
https://doi.org/10.1111/ajad.13050
Autor:
Mohammadali Nikoo, Kiana Kianpoor, Nooshin Nikoo, Sanam Javidanbardan, Alireza Kazemi, Fiona Choi, Marc Vogel, Ali Gholami, Saeed Tavakoli, James S. H. Wong, Ehsan Moazen‐Zadeh, Reza Givaki, Majid Jazani, Fatemeh Mohammadian, Nader Markazi Moghaddam, Christian Schütz, Kerry Jang, Shahin Akhondzadeh, Michael Krausz
Publikováno v:
Addiction (Abingdon, England)REFERENCES. 118(2)
To test if opium tincture (OT) was non-inferior to methadone in retaining participants in opioid agonist treatment (OAT).A Phase III, multi-centre, parallel-group, non-inferiority, double-blind randomized controlled trial with an allocation ratio of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a83fbed756be9dd9910982a497a4362
https://pubmed.ncbi.nlm.nih.gov/35971297
https://pubmed.ncbi.nlm.nih.gov/35971297
Autor:
Christian G. Schütz, Jessica Moe, Jean Nicolas Westenberg, Janet Suen, Jesse A. Sidhu, James S H Wong, Mohammadali Nikoo, Shane Arishenkoff, Nickie Mathew, Reinhard Michael Krausz, Donald E. G. Griesdale, Pouya Azar, Marc Vogel, Jennifer S. Wong
Publikováno v:
Addiction Science & Clinical Practice
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-10 (2021)
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-10 (2021)
Background Buprenorphine/naloxone (Suboxone) is a current first-line treatment for opioid use disorder (OUD). The standard induction method of buprenorphine/naloxone requires patients to be abstinent from opioids and therefore experience withdrawal s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab067dbe6567dc0b3912b995ee2e28f
https://doi.org/10.1101/2020.05.22.20106062
https://doi.org/10.1101/2020.05.22.20106062
